We are live on ! Find out more
SP

Syncona Portfolio Portfolio holdings

AUM $25.7M
1-Year Est. Return 13.32%
This Fund
S&P 500
This Quarter Est. Return
-34.45%
1 Year Est. Return
+13.32%
3 Year Est. Return
+8.47%
5 Year Est. Return
10 Year Est. Return
AUM
$26.4M
AUM Growth
-$26.6M
Cap. Flow
-$12.6M
Cap. Flow %
-47.93%
Top 10 Hldgs %
100%
Holding
3
New
Increased
Reduced
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
ACHL
Achilles Therapeutics
ACHL
+$12.6M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AUTL
1
Autolus Therapeutics
AUTL
$386M
$25.8M 97.81%
16,640,720
IPSC icon
2
Century Therapeutics
IPSC
$381M
$577K 2.19%
1,213,056
ACHL
3
DELISTED
Achilles Therapeutics
ACHL
-11,086,909
Closed -$12.6M

Similar funds

Syncona Portfolio's Q1 2025 Portfolio in Review

As of Q1 2025, Syncona Portfolio held 3 positions worth $26.4M, down 50% from $53M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Syncona Portfolio withdrew a net $12.6M in Q1 2025, closing 1 position. Its most notable exit was Achilles Therapeutics, an estimated $12.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Syncona Portfolio fully exited Achilles Therapeutics in Q1 2025, selling an estimated $12.6M.
  • Syncona Portfolio's ten largest holdings make up 100% of its $26.4M portfolio in Q1 2025.
  • Syncona Portfolio opened 0 new positions and closed 1 in Q1 2025.
  • Syncona Portfolio's portfolio value fell 50% quarter-over-quarter to $26.4M.

Based on Syncona Portfolio's 13F filing for Q1 2025, filed 7 May 2025.